BIOSGN — Biosergen AB Balance Sheet
0.000.00%
Last trade - 00:00- SEK17.28m
- SEK15.40m
Annual balance sheet for Biosergen AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | ARS | ARS | PRESS | PRESS |
| Standards: | SAS | SAS | — | — |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Short Term Investments | 0.589 | 21.7 | 29.3 | 1.88 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 1.22 | 3.17 | 4.64 | 5.32 |
| Prepaid Expenses | ||||
| Total Current Assets | 4.8 | 29.5 | 34 | 7.2 |
| Total Assets | 4.8 | 29.5 | 34 | 7.2 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 15.7 | 9.25 | 11.2 | 5.08 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 15.7 | 9.25 | 11.2 | 5.08 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | -10.9 | 20.2 | 22.8 | 2.12 |
| Total Liabilities & Shareholders' Equity | 4.8 | 29.5 | 34 | 7.2 |
| Total Common Shares Outstanding |